Dexmedetomidine Hydrochloride Injection: illegible lot number and expiry date on label
Last updated
Summary
Product
Dexmedetomidine Hydrochloride Injection
Issue
Health products - Labelling
What to do
Consult your health care professional if you have any health concerns.
Distribution
Manitoba
New Brunswick
Ontario
Quebec
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Dexmedetomidine Hydrochloride Injection |
Dexmedetomidine Hydrochloride Injection |
DIN 02487365 |
Solution |
DEXMEDETOMIDINE HYDROCHLORIDE INJECTION 4 mcg/mL (200 mcg/50 mL) |
AGA201 |
Issue
Lot number and expiry date on vial label of affected lots may become illegible.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of Recall: Wholesalers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Juno Pharmaceuticals Corp.
402 - 2233 Argentia Road, Mississauga
ON, L5N 2X7
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
Manitoba
New Brunswick
Ontario
Quebec
Recall class
Type III
Identification number
RA-74081
Get notified
Receive notifications for new and updated recalls and alerts by category.